Target Name: UAP1
NCBI ID: G6675
Review Report on UAP1 Target / Biomarker Content of Review Report on UAP1 Target / Biomarker
UAP1
Other Name(s): Sperm associated antigen 2 | UDP-N-acetylhexosamine pyrophosphorylase isoform a | OTTHUMP00000032326 | UDP-N-acetylhexosamine pyrophosphorylase 1 | OTTHUMP00000032327 | AGX2 | UDP-N-acetylglucosamine pyrophosphorylase 1, transcript variant 1 | Sperm-associated antigen 2 | AGX-1 | sperm associated antigen 2 | AGX-2 | UAP1_HUMAN | AGX | UDP-N-acetylglucosamine pyrophosphorylase | SPAG2 | AGX1 | UDP-N-acetylhexosamine pyrophosphorylase | UAP1 variant 1 | UDP-N-acetylglucosamine pyrophosphorylase 1 | Antigen X | antigen X | UDP-N-acetylgalactosamine pyrophosphorylase | UDP-N-acetylglucosamine diphosphorylase 1 | testis tissue sperm-binding protein Li 37a

Understanding The Role of UAP1 in Various Biological Processes

UAP1 (Sperm associated antigen 2) is a protein that is expressed in high levels in the testes and other body tissues. It is a type of glycoprotein that consists of a single transmembrane domain and a cytoplasmic tail. UAP1 has been identified as a potential drug target and has been shown to play a role in various biological processes, including sperm function, testicular cancer, and neurodegenerative diseases.

UAP1 is expressed in the testes, where it is involved in the process of meiosis, which is the formation of sperm cells. In meiosis, UAP1 helps to ensure that the correct number of chromosomes are produced and that the genetic material is accurately duplicated. It is also involved in the development and maintenance of the germ plasm, which is the substance that gives rise to new organisms after fertilization.

In addition to its role in meiosis, UAP1 is also involved in the regulation of cell signaling processes. It has been shown to play a role in the regulation of cell adhesion, as well as in the regulation of ion channels and signaling pathways that are involved in the transfer of electrical signals within cells.

UAP1 has also been shown to be involved in the development and progression of testicular cancer. Studies have shown that high levels of UAP1 are associated with an increased risk of testicular cancer, and that inhibiting UAP1 activity may be a useful therapeutic approach for this disease.

In addition to its potential as a drug target, UAP1 is also a potential biomarker for the diagnosis and prognosis of various diseases. For example, high levels of UAP1 have been shown to be associated with poor prognosis in patients with neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Additionally, UAP1 has been shown to be involved in the development of certain types of cancer, including breast cancer and ovarian cancer, and may be a useful biomarker for the diagnosis and prognosis of these diseases.

Overall, UAP1 is a protein that has important roles in various biological processes, including meiosis, cell signaling, and cancer development. Its potential as a drug target and biomarker make it an attractive target for further research and development. Further studies are needed to fully understand the role of UAP1 in these processes and to develop safe and effective therapies that can be used to treat or prevent various diseases.

Protein Name: UDP-N-acetylglucosamine Pyrophosphorylase 1

Functions: Converts UTP and GlcNAc-1-P into UDP-GlcNAc, and UTP and GalNAc-1-P into UDP-GalNAc. Isoform AGX1 has 2 to 3 times higher activity towards GalNAc-1-P, while isoform AGX2 has 8 times more activity towards GlcNAc-1-P

The "UAP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about UAP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

UAP1L1 | UBA1 | UBA2 | UBA3 | UBA5 | UBA52 | UBA52P1 | UBA6 | UBA6-DT | UBA7 | UBAC1 | UBAC2 | UBAC2-AS1 | UBALD1 | UBALD2 | UBAP1 | UBAP1L | UBAP2 | UBAP2L | UBASH3A | UBASH3B | UBB | UBBP1 | UBBP2 | UBBP4 | UBC | UBD | UBDP1 | UBE2A | UBE2B | UBE2C | UBE2CP3 | UBE2CP4 | UBE2D1 | UBE2D2 | UBE2D3 | UBE2D3P1 | UBE2D4 | UBE2DNL | UBE2E1 | UBE2E2 | UBE2E3 | UBE2F | UBE2F-SCLY | UBE2FP1 | UBE2G1 | UBE2G2 | UBE2H | UBE2HP1 | UBE2I | UBE2J1 | UBE2J2 | UBE2K | UBE2L1 | UBE2L3 | UBE2L6 | UBE2M | UBE2MP1 | UBE2N | UBE2NL | UBE2O | UBE2Q1 | UBE2Q2 | UBE2Q2P1 | UBE2Q2P11 | UBE2Q2P13 | UBE2Q2P16 | UBE2Q2P2 | UBE2QL1 | UBE2R2 | UBE2R2-AS1 | UBE2S | UBE2T | UBE2U | UBE2V1 | UBE2V1P2 | UBE2V1P9 | UBE2V2 | UBE2V2P1 | UBE2W | UBE2Z | UBE3A | UBE3B | UBE3C | UBE3D | UBE4A | UBE4B | UBFD1 | UBIAD1 | Ubiquitin carboxyl-terminal hydrolase 17-like protein 24 | Ubiquitin E3 ligase (ASB2, TCEB1, TCEB2, CUL5, RNF7) complex | UBL3 | UBL4A | UBL4B | UBL5 | UBL5P3 | UBL7 | UBL7-DT | UBLCP1 | UBN1